Cancer risk rises after childhood organ transplant: study

April 26, 2017 by Gia Miller, Healthday Reporter

(HealthDay)—Children given an organ transplant have a substantially higher risk of developing cancer—in some cases up to 200 times higher—than the general population, a new study finds.

But the individual risk of any one child getting still remains very small, the study authors stressed.

Overall, the U.S. National Cancer Institute (NCI) study found that the risk for cancer among children who received transplants was 19 times higher than in the general population.

Non-Hodgkin's lymphoma was the cancer with a 200 times higher risk. Seventy-one percent of those who developed cancer after a pediatric organ transplant had non-Hodgkin's lymphoma, the study findings showed.

"We knew going into the study that the risk of lymphoma would be very high," explained Dr. Eric Engels, the study's senior investigator.

"That's been seen in much smaller studies, and it's been seen when researchers have looked at the entire transplant population. But we were surprised by how much of the cancer burden in this population of was dominated by non-Hodgkin's lymphoma—71 percent is a really, really high proportion," Engels said. He works in the NCI's division of cancer epidemiology and genetics.

The one bright spot in the study was that although the cancer risk is elevated, most children who receive a transplant don't get cancer. Fewer than 400 out of nearly 18,000 transplant recipients developed some form of cancer in an average of about four years of follow-up.

In cases where cancer did develop, the researchers said two factors were likely to blame. One is immune-suppressing medications that are necessary after a transplant. The other is the Epstein-Barr .

Organ transplant recipients receive immunosuppressant medications after surgery to help the body accept the new organ. In adults, research has shown these medications put patients at a high risk for a number of cancers because the immune system has trouble keeping cancer cells at bay.

The weakened immune system also puts at risk of infections, such as the Epstein-Barr virus.

According to Engels, the Epstein-Barr virus can be transmitted directly from the new organ to the recipient. The virus can also be transmitted through contact with someone who has the virus, such as a family member or someone else in the hospital or community.

Dr. Daniel Weschler is associate professor of pediatric hematology and oncology at Duke University. He co-wrote an editorial accompanying the study, which was published in the May issue of Pediatrics.

"Epstein-Barr virus can cause mononucleosis, and about 70 to 80 percent of the population has been exposed to it at some point. It is also associated with non-Hodgkin's lymphoma and Hodgkin's lymphoma, and other tumors as well," Weschler explained.

The new study included nearly 18,000 pediatric transplant patients in the United States. The largest previous study, from Sweden, included less than 600 transplant recipients, the study authors noted.

Engels said that children are an understudied subgroup of the transplant population. The researchers suspected that kids might have a different pattern of cancer risk than adults after transplant.

The study found that the risk of Hodgkin's lymphoma was increased 19-fold. The risk of leukemia was four times higher among pediatric transplant recipients. There was also a higher risk of developing other cancers, such as multiple myeloma, and liver and kidney cancer.

This research raises some concerns about transplants, Weschler said. It also highlights the need to better understand why these cancers occur and exactly how immune suppression medications work to prevent rejection.

"The field of immunotherapy is still in its infancy," Weschler said. "We still need to learn more about the power of the treatments, but also their potential side effects."

Both experts agreed that the results of this study shouldn't dissuade parents from seeking an for their child.

"The benefits of transplantation far outweigh the risks we are describing," Engels said.

"While cancer is a concern, for children or adolescents who need an organ, that's a life-saving operation. It has revolutionized the treatment of people with severe organ disease. Parents should not take this evidence and let it give them pause about proceeding with a transplant if their child really needs one," Engels said.

Weschler stressed that while doctors do monitor for Epstein-Barr virus, parents should also be vigilant and not ignore symptoms or signs.

"If your child complains of pain in the neck, has difficulty breathing or has belly pain that doesn't go away, you need to look at the possibility of tumors," he said.

The hope is that this research will encourage further study of the Epstein-Barr virus—either a vaccine or better antiviral medications to treat the virus, according to Weschler.

Explore further: Increased cancer risk for childhood kidney recipients

More information: Eric Engels, M.D., cancer epidemiology and genetics division, U.S. National Cancer Institute; Daniel Weschler, M.D., Ph.D., associate professor of pediatric hematology and oncology, Duke University, Durham, N.C.; May 2017, Pediatrics

There's more on organ transplants at the U.S. Department of Health and Human Services.

Related Stories

Increased cancer risk for childhood kidney recipients

April 5, 2017
(HealthDay)—Childhood kidney recipients have increased cancer risk, according to a study published online March 29 in the American Journal of Transplantation.

Recipients of organ transplants at increased risk for broad range of cancers

November 1, 2011
Patients who have received a solid organ transplant, such as kidney, liver, heart or lung, have an overall cancer risk that is double that of the general population, with an increased risk for many different types of malignancies, ...

Inconsistent guidelines for screening transplant recipients at higher cancer risk

August 30, 2016
People who have received organ transplants are at higher risk of developing and dying of cancer than the general population. Yet a new study has found cancer screening guidelines for this group are inconsistent as is the ...

Higher cancer death rate associated with solid-organ transplant recipients

January 7, 2016
In solid-organ transplant recipients, the cancer death rate was higher than in the general population in a new study from Ontario, Canada, published online by JAMA Oncology.

Transplant recipients more likely to develop aggressive melanoma

August 13, 2015
Organ transplant recipients are twice as likely to develop melanoma as people who do not undergo a transplant, and three times more likely to die of the dangerous skin cancer, suggests new research led by a Johns Hopkins ...

Organ recipients with previous cancers linked to higher death rates, new cancers

April 22, 2016
People who had cancer before receiving an organ transplant were more likely to die of any cause, die of cancer or develop a new cancer than organ recipients who did not previously have cancer, a new paper has found. However, ...

Recommended for you

Similarities found in cancer initiation in kidney, liver, stomach, pancreas

February 21, 2018
Recent research at Washington University School of Medicine in St. Louis demonstrated that mature cells in the stomach sometimes revert back to behaving like rapidly dividing stem cells. Now, the researchers have found that ...

Genes activated in metastasis also drive the first stages of tumour growth

February 21, 2018
In spite of the difference between the cell functions responsible for giving rise to a tumour and that give rise to metastasis, studies at IRB Barcelona using the fly Drosophila melanogaster reveal that some genes can drive ...

Researchers discover novel mechanism linking changes in mitochondria to cancer cell death

February 20, 2018
To stop the spread of cancer, cancer cells must die. Unfortunately, many types of cancer cells seem to use innate mechanisms that block cancer cell death, therefore allowing the cancer to metastasize. While seeking to further ...

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.